These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28596424)
1. S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression. Prieto D; Sotelo N; Seija N; Sernbo S; Abreu C; Durán R; Gil M; Sicco E; Irigoin V; Oliver C; Landoni AI; Gabus R; Dighiero G; Oppezzo P Blood; 2017 Aug; 130(6):777-788. PubMed ID: 28596424 [TBL] [Abstract][Full Text] [Related]
2. S100-A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF-κB pathway in polycystic ovary syndrome. Li H; Huang X; Chang X; Yao J; He Q; Shen Z; Ji Y; Wang K J Cell Mol Med; 2020 Jan; 24(1):114-125. PubMed ID: 31568644 [TBL] [Abstract][Full Text] [Related]
3. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Paggetti J; Haderk F; Seiffert M; Janji B; Distler U; Ammerlaan W; Kim YJ; Adam J; Lichter P; Solary E; Berchem G; Moussay E Blood; 2015 Aug; 126(9):1106-17. PubMed ID: 26100252 [TBL] [Abstract][Full Text] [Related]
4. Regulation of S100As Expression by Inflammatory Cytokines in Chronic Lymphocytic Leukemia. Mitrović Ajtić O; Subotički T; Diklić M; Đikić D; Vukotić M; Dragojević T; Živković E; Antić D; Čokić V Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805957 [TBL] [Abstract][Full Text] [Related]
6. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675 [TBL] [Abstract][Full Text] [Related]
7. Induction of endothelial cell proliferation and von Willebrand factor expression and secretion by leukemic plasma of patients with chronic lymphocytic leukemia before and after inhibition of NF-κB. Shahidi M; Mohsen Razavi S; Hayat P Blood Coagul Fibrinolysis; 2016 Sep; 27(6):711-6. PubMed ID: 27472040 [TBL] [Abstract][Full Text] [Related]
8. ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia. Krenn PW; Hofbauer SW; Pucher S; Hutterer E; Hinterseer E; Denk U; Asslaber D; Ganghammer S; Sternberg C; Neureiter D; Aberger F; Wickström SA; Egle A; Greil R; Hartmann TN Cancer Res; 2016 Apr; 76(8):2186-96. PubMed ID: 26837762 [TBL] [Abstract][Full Text] [Related]
10. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions. Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692 [TBL] [Abstract][Full Text] [Related]
11. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia. Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565 [TBL] [Abstract][Full Text] [Related]
12. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway. Li X; Wang S; Zhu R; Li H; Han Q; Zhao RC J Hematol Oncol; 2016 Apr; 9():42. PubMed ID: 27090786 [TBL] [Abstract][Full Text] [Related]
13. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625 [TBL] [Abstract][Full Text] [Related]
15. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Yeh YY; Ozer HG; Lehman AM; Maddocks K; Yu L; Johnson AJ; Byrd JC Blood; 2015 May; 125(21):3297-305. PubMed ID: 25833959 [TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression. Wu L; Zhang X; Zhang B; Shi H; Yuan X; Sun Y; Pan Z; Qian H; Xu W Tumour Biol; 2016 Sep; 37(9):12169-12180. PubMed ID: 27220495 [TBL] [Abstract][Full Text] [Related]
17. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells. Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia. Lopez-Guerra M; Colomer D Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715 [TBL] [Abstract][Full Text] [Related]
19. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369 [TBL] [Abstract][Full Text] [Related]
20. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. Hahn M; Bürckert JP; Luttenberger CA; Klebow S; Hess M; Al-Maarri M; Vogt M; Reißig S; Hallek M; Wienecke-Baldacchino A; Buch T; Muller CP; Pallasch CP; Wunderlich FT; Waisman A; Hövelmeyer N Leukemia; 2018 Jan; 32(1):72-82. PubMed ID: 28566736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]